Peptide Mapping: A Quality by Design (QbD) Approach
Applications | 2017 | Agilent TechnologiesInstrumentation
HPLC
IndustriesPharma & Biopharma, Proteomics
ManufacturerAgilent Technologies
Key wordsqbd, design, method, tangent, doe, peptide, mapping, hold, cmas, space, intermediate, experiment, oven, development, final, variables, pars, rectangle, robust, best, screening, temperature, pump, fusion, number, software, strong, peaks, openlab, optimization, cmps, verify, performance, solvent, understanding, answer, resolution, point, time, goals, obtained, simulator, border, mean, export, robustness, column, additive, predicted, establish
Similar PDF
Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin
2014|Agilent Technologies|Applications
Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin Application Note Pharmaceutical QA/QC Authors Abstract Vinayak AK and Syed Salman Lateef Quality-by-Design (QbD) approach emphasizes risk management and sound Agilent Technologies Inc, science. Its application in analytical method development…
Key words
qbd, qbdmethod, methodpass, passdevelopment, developmentvariable, variablefusion, fusionapi, apiatorvastatin, atorvastatinhold, holdvalidation, validationcmvs, cmvsgradient, gradientrobustness, robustnessoxidative, oxidativecmv
QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology
2015|Agilent Technologies|Applications
QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology Application Note Pharmaceutical QA/QC Author Abstract Vinayak A.K In this Application Note, a method was developed…
Key words
qbd, qbdmethod, methodhplc, hplccmps, cmpsdesign, designspace, spaceuhplc, uhplccmas, cmaspars, parscma, cmafusion, fusionoptimization, optimizationstrong, strongagilent, agilenttransferred
Quality‑by‑Design Approach to Stability Indicating Method Development for Linagliptin Drug Product
2014|Agilent Technologies|Applications
Quality-by-Design Approach to Stability Indicating Method Development for Linagliptin Drug Product Application Note Pharmaceutical QA/QC Authors Abstract Syed Salman Lateef and Vinayak AK A traditional approach to method development could fail to meet desired Agilent Technologies, Inc. separation during validation,…
Key words
method, methodvariables, variablesfusion, fusionlinagliptin, linagliptinqbd, qbddesign, designdevelopment, developmentdoe, doegradient, gradientphase, phaseparameters, parametersmodeled, modeledindicating, indicatingapi, apiquality
Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC
2017|Agilent Technologies|Applications
Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC An Efficient Method Development Workflow Combined with ISET-mediated Method Transfer Under Waters Empower 3 CDS Control Application Note Pharmaceutical Developments and QA/QC Authors Abstract Vinayak A.K and Andreas Tei This…
Key words
imp, impqbd, qbdmethod, methodiset, isetuhplc, uhplcapi, apiemulation, emulationmin, minzorbax, zorbaximpurity, impurityhplc, hplcamlodipine, amlodipinetime, timefusion, fusionagilent